[1]
“FOSTAMATINIB AS A NOVEL THERAPEUTIC APPROACH FOR REFRACTORY IMMUNE THROMBOCYTOPENIA IN AN HIV-POSITIVE PATIENT: A CASE REPORT”, Eur. J. Emerg. Clin. Case Rep., vol. 1, no. 01, pp. 39–45, Dec. 2024, Accessed: Jan. 15, 2026. [Online]. Available: https://parthenonfrontiers.com/index.php/ejeccr/article/view/26